Web search
[PDF Download]
SEC Filings
Annual Report
Presentations
Contact Us
Contact Us
 
Home>
 FileTypeDate
8-K Current report, items 2.02, 7.01, and 9.012010-04-15
10-K Annual report [Section 13 and 15(d), not S-K Item 405]2010-04-14
NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4052010-03-31
3 Initial statement of beneficial ownership of securities2010-03-12
UPLOAD LETTER2010-03-02
10-K/A [Amend][Cover]Annual report [Section 13 and 15(d), not S-K Item 405]2010-01-22
CORRESP [Cover]Correspondence2009-12-23
UPLOAD LETTER2009-12-10
8-K Current report, items 2.02 and 9.012009-11-17
10-Q Quarterly report [Sections 13 or 15(d)]2009-11-16
3 Initial statement of beneficial ownership of securities2009-11-12
8-K/A [Amend]Current report, items 4.01 and 9.012009-10-23
8-K Current report, item 5.022009-08-28
8-K Current report, items 4.01 and 9.012009-08-26
8-K Current report, items 2.02 and 9.012009-08-18
10-Q Quarterly report [Sections 13 or 15(d)]2009-08-14
8-K Current report, items 8.01 and 9.012009-06-10
8-K Current report, items 2.02 and 9.012009-05-18
10-Q Quarterly report [Sections 13 or 15(d)]2009-05-15
DEF 14A Other definitive proxy statements2009-04-30
1 2 3 4 5 6
Home | About Us | News & Events | Products | Research / Development | Sales / Marketing | Investor Relations
China Shenghuo Pharmaceutical Holdings, Inc.
No. 2, Jing You Road Kunming National Economy & Technology Developing District P.R. China, 650217
Phone: +86- (0)871-7282 608 E-mail: qionghua_kmsh@163.com